212 related articles for article (PubMed ID: 33045468)
21. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.
Li Y; Zhang Y; Dorweiler B; Cui D; Wang T; Woo CW; Brunkan CS; Wolberger C; Imai S; Tabas I
J Biol Chem; 2008 Dec; 283(50):34833-43. PubMed ID: 18945671
[TBL] [Abstract][Full Text] [Related]
22. eNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt/mTORC2 signaling.
Bermudez T; Sammani S; Song JH; Hernon VR; Kempf CL; Garcia AN; Burt J; Hufford M; Camp SM; Cress AE; Desai AA; Natarajan V; Jacobson JR; Dudek SM; Cancio LC; Alvarez J; Rafikov R; Li Y; Zhang DD; Casanova NG; Bime C; Garcia JGN
Sci Rep; 2022 Jan; 12(1):696. PubMed ID: 35027578
[TBL] [Abstract][Full Text] [Related]
23. SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice.
Yoon MJ; Yoshida M; Johnson S; Takikawa A; Usui I; Tobe K; Nakagawa T; Yoshino J; Imai S
Cell Metab; 2015 May; 21(5):706-17. PubMed ID: 25921090
[TBL] [Abstract][Full Text] [Related]
24. Extracellular Nampt (eNampt/visfatin/PBEF) directly and indirectly stimulates ACTH and CCL2 protein secretion from isolated rat corticotropes.
Celichowski P; Jopek K; Szyszka M; Milecka P; Tyczewska M; Sakhanova S; Szaflarski W; Malendowicz LK; Ruciński M
Adv Clin Exp Med; 2021 Sep; 30(9):967-980. PubMed ID: 34418332
[TBL] [Abstract][Full Text] [Related]
25. NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis.
Park KH; Kim DK; Huh YH; Lee G; Lee SH; Hong Y; Kim SH; Kook MS; Koh JT; Chun JS; Lee SE; Ryu JH
Exp Mol Med; 2017 Aug; 49(8):e368. PubMed ID: 28819322
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype.
Kuehnemann C; Hu KQ; Butera K; Patel SK; Bons J; Schilling B; Aguayo-Mazzucato C; Wiley CD
Front Endocrinol (Lausanne); 2022; 13():935106. PubMed ID: 35909566
[TBL] [Abstract][Full Text] [Related]
27. Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.
Carbone F; Liberale L; Bonaventura A; Vecchiè A; Casula M; Cea M; Monacelli F; Caffa I; Bruzzone S; Montecucco F; Nencioni A
Compr Physiol; 2017 Mar; 7(2):603-621. PubMed ID: 28333382
[TBL] [Abstract][Full Text] [Related]
28. Circulating eNAMPT as a biomarker in the critically ill: acute pancreatitis, sepsis, trauma, and acute respiratory distress syndrome.
Bime C; Casanova NG; Camp SM; Oita RC; Ndukum J; Hernon VR; Oh DK; Li Y; Greer PJ; Whitcomb DC; Papachristou GI; Garcia JGN
BMC Anesthesiol; 2022 Jun; 22(1):182. PubMed ID: 35705899
[TBL] [Abstract][Full Text] [Related]
29. Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine.
Grolla AA; Travelli C; Genazzani AA; Sethi JK
Br J Pharmacol; 2016 Jul; 173(14):2182-94. PubMed ID: 27128025
[TBL] [Abstract][Full Text] [Related]
30. Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice.
Yoshida M; Satoh A; Lin JB; Mills KF; Sasaki Y; Rensing N; Wong M; Apte RS; Imai SI
Cell Metab; 2019 Aug; 30(2):329-342.e5. PubMed ID: 31204283
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
[TBL] [Abstract][Full Text] [Related]
32. eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
Gao L; Ramirez FJ; Cabrera JTO; Varghese MV; Watanabe M; Tsuji-Hosokawa A; Zheng Q; Yang M; Razan MR; Kempf CL; Camp SM; Wang J; Garcia JGN; Makino A
Diabetologia; 2024 Jun; ():. PubMed ID: 38898303
[TBL] [Abstract][Full Text] [Related]
33. Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment.
Kieswich J; Sayers SR; Silvestre MF; Harwood SM; Yaqoob MM; Caton PW
Diabetologia; 2016 Nov; 59(11):2477-2486. PubMed ID: 27541013
[TBL] [Abstract][Full Text] [Related]
34. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
[TBL] [Abstract][Full Text] [Related]
35. Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis.
Sun BL; Sun X; Kempf CL; Song JH; Casanova NG; Camp SM; Reyes Hernon V; Fallon M; Bime C; Martin DR; Travelli C; Zhang DD; Garcia JGN
FASEB J; 2023 Mar; 37(3):e22825. PubMed ID: 36809677
[TBL] [Abstract][Full Text] [Related]
36. Increased Nicotinamide Phosphoribosyltransferase in Rhabdomyosarcomas and Leiomyosarcomas Compared to Skeletal and Smooth Muscle Tissue.
Vora M; Ansari J; Shanti RM; Veillon D; Cotelingam J; Coppola D; Shackelford RE
Anticancer Res; 2016 Feb; 36(2):503-7. PubMed ID: 26851003
[TBL] [Abstract][Full Text] [Related]
37. Design of FK866-Based Degraders for Blocking the Nonenzymatic Functions of Nicotinamide Phosphoribosyltransferase.
Lu T; Chen F; Yao J; Bu Z; Kyani A; Liang B; Chen S; Zheng Y; Liang H; Neamati N; Liu Y
J Med Chem; 2024 May; 67(10):8099-8121. PubMed ID: 38722799
[TBL] [Abstract][Full Text] [Related]
38. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas.
Olesen UH; Hastrup N; Sehested M
APMIS; 2011 Apr; 119(4-5):296-303. PubMed ID: 21492230
[TBL] [Abstract][Full Text] [Related]
39. The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer.
Audrito V
EBioMedicine; 2020 Dec; 62():103109. PubMed ID: 33160209
[No Abstract] [Full Text] [Related]
40. Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.
Rosti V; Campanelli R; Massa M; Viarengo G; Villani L; Poletto V; Bonetti E; Catarsi P; Magrini U; Grolla AA; Travelli C; Genazzani AA; Barosi G
Am J Hematol; 2016 Jul; 91(7):709-13. PubMed ID: 27074203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
